loading

Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
26.89%
2.3398
3.2003 3.2257 2.8837 3.2036
Operating Income/Loss
26.89%
-2.3398
-3.2003 -3.2257 -2.8837 -3.2036
Income/Loss From Continuing Operations Before Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Income/Loss From Continuing Operations After Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Net Income/Loss
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 3.1343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.1547
- - - -
Diluted Average Shares
5.1547
- - - -
Basic Earnings Per Share
-0.45
- - - -
Diluted Earnings Per Share
-0.45
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):